Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in biostatistics and statistical programming, today announced it has acquired August Research. The acquisition of August Research establishes a European footprint for Everest to scale its full-service clinical trial delivery and operational capabilities through the Company’s operations across 14 countries in Western and Eastern Europe. August Research founders Dana Leff Niedzielska and Lukasz Niedzielski will continue as key executive leaders with the business post-transaction.
“As we were approaching the next chapter for August Research, we wanted a true partnership where we could achieve our visions for growth together” said Dana Niedzielska, CEO of August. “Jin, Irene and the entire Everest team, along with Arlington, present the right opportunity for us to realize those objectives and be part of an organization providing exceptional quality, service and on-time delivery to help advance life-changing research.”